首页> 外文OA文献 >An update on molecular cat allergens: Fel d 1 and what else? Chapter 1: Fel d 1, the major cat allergen
【2h】

An update on molecular cat allergens: Fel d 1 and what else? Chapter 1: Fel d 1, the major cat allergen

机译:关于分子猫过敏原的更新:Fel D 1和其他什么?第1章:FEL D 1,主要猫过敏原

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Abstract Background Cats are the major source of indoor inhalant allergens after house dust mites. The global incidence of cat allergies is rising sharply, posing a major public health problem. Ten cat allergens have been identified. The major allergen responsible for symptoms is Fel d 1, a secretoglobin and not a lipocalin, making the cat a special case among mammals. Main body Given its clinical predominance, it is essential to have a good knowledge of this allergenic fraction, including its basic structure, to understand the new exciting diagnostic and therapeutic applications currently in development. The recent arrival of the component-resolved diagnosis, which uses molecular allergens, represents a unique opportunity to improve our understanding of the disease. Recombinant Fel d 1 is now available for in vitro diagnosis by the anti-Fel d 1 specific IgE assay. The first part of the review will seek to describe the recent advances related to Fel d 1 in terms of positive diagnosis and assessment of disease severity. In daily practice, anti-Fel d 1 IgE tend to replace those directed against the overall extract but is this attitude justified? We will look at the most recent arguments to try to answer this question. In parallel, a second revolution is taking place thanks to molecular engineering, which has allowed the development of various forms of recombinant Fel d 1 and which seeks to modify the immunomodulatory properties of the molecule and thus the clinical history of the disease via various modalities of anti-Fel d 1-specific immunotherapy. We will endeavor to give a clear and practical overview of all these trends.
机译:摘要背景猫是屋尘螨后的室内吸入性过敏原的主要来源。猫过敏症的全球发病率急剧上升,有引发重大的公共卫生问题。十猫过敏原已确定。负责症状的主要过敏原为魔d 1,secretoglobin而不是脂质运载蛋白,使猫哺乳动物中的一个特例。主体鉴于其临床优势,就必须有这种过敏的分数有很好的了解,包括它的基本结构,目前正在了解新的令人兴奋的诊断和治疗应用的发展。而近期部分分辨诊断的到来,它采用分子过敏原,表示要提高我们本病的认识一个独特的机会。重组魔d 1现在可用于体外诊断由反魔d 1特异性IgE测定。审查的第一部分将试图描述近期阳性诊断和疾病严重程度的评估方面与恶魔d 1的进步。在日常实践中,反邪d 1的IgE趋向,以取代那些针对整体提取,但这种态度是否合理?我们将着眼于最近的争论,试图回答这个问题。并行地,第二回转正在发生由于分子工程,这也使各种形式的重组魔d 1和其目的是改变分子的免疫调节性质,并通过各种方式的疾病的这样的临床病史的发展抗魔d 1特异性的免疫治疗。我们将努力给所有这些趋势的明确和实用的概述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号